Efficacy of risk-reducing salpingo-oophorectomy in BRCA1–2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC)-Reference-Cited by-同舟云学术

Efficacy of risk-reducing salpingo-oophorectomy in BRCA1–2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC)

Published:2021-11 Issue:2 Volume:163 Page:364-370
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Saccardi Carlo,Zovato Stefania,Spagnol Giulia,Bonaldo Giulio,Marchetti Matteo,Alessandrini Lara,Tognazzo Silvia,Guerriero Angela,Vitagliano Amerigo,Laganà Antonio Simone,Noventa Marco

Funder

University of Padua

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference39 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2;King;Science,2003

3. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews;Struewing;N. Engl. J. Med.,1997

4. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program;Brose;J. Natl. Cancer Inst.,2002

5. Meta-analysis of BRCA1 and BRCA2 penetrance;Chen;J. Clin. Oncol.,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers;JNCI: Journal of the National Cancer Institute;2024-06-27

2. Incidental Serous Tubal Intraepithelial Carcinoma Finding in a Nepalese Patient Undergoing Opportunistic Salpingectomy and the Discovery of a BRCA1 Pathogenic Variant;O&G Open;2024-06

3. Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation;Journal of Gynecology Obstetrics and Human Reproduction;2023-10

4. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy;International Journal of Gynecologic Cancer;2023-08-04

5. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives;Clinical and Experimental Obstetrics & Gynecology;2023-08-02